Codexis to participate in presentations on enzymatic synthesis at the annual RNA Leaders meeting Page 1

REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme technology company, today announced that the company will participate in a presentation and panel discussion at the upcoming RNA Leaders Annual Meeting, being held September 4-5, 2024 in San Diego, California. The company’s presentations will focus on the use of enzymes to drive the scalable and cost-effective production of short inhibitory ribonucleic acid (siRNA) duplexes.

During a keynote panel presentation, Stefan Lutz, PhD, Senior Vice President of Research at Codexis, and other RNA industry leaders will discuss how the biopharmaceutical industry is developing novel solutions to improve RNA production, expand manufacturing capacity, and develop new approaches to streamline clinical trials and standardize protocols.